TLSA Latest Press Releases

-- June 15, 2026 --

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman Globe Newswire 7:00 AM

-- May 28, 2026 --

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York Globe Newswire 7:00 AM

-- May 21, 2026 --

Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial Globe Newswire 11:00 AM

-- May 19, 2026 --

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Globe Newswire 7:00 AM

-- May 14, 2026 --

Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab Globe Newswire 7:00 AM

-- April 16, 2026 --

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function Globe Newswire 7:00 AM

-- April 14, 2026 --

Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress Globe Newswire 7:00 AM

-- April 1, 2026 --

Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging Globe Newswire 7:00 AM

-- February 25, 2026 --

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software